-
1
-
-
60549102095
-
Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer - Comparison between Adjuvant! St. Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial
-
PMID:18824499; DOI:10.1093/annonc/mdn590.
-
Schmidt M, Victor A, Bratzel D, Boehm D, Cotarelo C, Lebrecht A, et al. Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer - comparison between Adjuvant! St. Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial. Ann Oncol 2009; 20:258- 64; PMID:18824499; DOI:10.1093/annonc/mdn590.
-
(2009)
Ann Oncol
, vol.20
, pp. 258-264
-
-
Schmidt, M.1
Victor, A.2
Bratzel, D.3
Boehm, D.4
Cotarelo, C.5
Lebrecht, A.6
-
2
-
-
66149098560
-
Coordinates in the universe of node-negative breast cancer revisited
-
PMID:19318558; DOI:10.1158/0008-5472.CAN-08-4013
-
Schmidt M, Hengstler J, von Torne C, Koelbl H, Gehrmann M. Coordinates in the universe of node-negative breast cancer revisited. Cancer Res 2009; 69:2695-8; PMID:19318558; DOI:10.1158/0008-5472.CAN-08-4013.
-
(2009)
Cancer Res
, vol.69
, pp. 2695-2698
-
-
Schmidt, M.1
Hengstler, J.2
Von Torne, C.3
Koelbl, H.4
Gehrmann, M.5
-
3
-
-
45149096576
-
Trends in breast cancer during three decades in Denmark: Stage at diagnosis, surgical management and survival
-
PMID:18465319; DOI:10.1080/02841860801982758
-
Jensen AR, Madsen AH, Overgaard J. Trends in breast cancer during three decades in Denmark: stage at diagnosis, surgical management and survival. Acta Oncol 2008; 47:537-44; PMID:18465319; DOI:10.1080/02841860801982758.
-
(2008)
Acta Oncol
, vol.47
, pp. 537-544
-
-
Jensen, A.R.1
Madsen, A.H.2
Overgaard, J.3
-
4
-
-
79952273599
-
Screening for breast cancer with mammography
-
PMID:21249649.
-
Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2011; 1877; PMID:21249649.
-
(2011)
Cochrane Database Syst Rev
, vol.1877
-
-
Gøtzsche, P.C.1
Nielsen, M.2
-
5
-
-
0029740257
-
The New Mexico mammography project. Screening mammography performance in albuquerque, New Mexico, 1991 to 1993
-
PMID:8859186; DOI:10.1002/(SICI)1097-0142(19961015)78:8<1731:: AIDCNCR13>3.0.CO;2-Z
-
Rosenberg RD, Lando JF, Hunt WC, Darling RR, Williamson MR, Linver MN, et al. The New Mexico mammography project. screening mammography performance in albuquerque, New Mexico, 1991 to 1993. Cancer 1996; 78:1731-9; PMID:8859186; DOI:10.1002/(SICI)1097-0142(19961015)78:8<1731::AIDCNCR13>3.0.CO;2-Z.
-
(1996)
Cancer
, vol.78
, pp. 1731-1739
-
-
Rosenberg, R.D.1
Lando, J.F.2
Hunt, W.C.3
Darling, R.R.4
Williamson, M.R.5
Linver, M.N.6
-
6
-
-
1942533551
-
Survival of women with breast cancer in Ottawa, Canada: Variation with age, stage, histology, grade and treatment
-
PMID:15026792; DOI:10.1038/sj.bjc.6601662
-
Ugnat AM, Xie L, Morriss J, Semenciw R, Mao Y. Survival of women with breast cancer in Ottawa, Canada: variation with age, stage, histology, grade and treatment. Br J Cancer 2004; 90:1138-43; PMID:15026792; DOI:10.1038/sj.bjc. 6601662.
-
(2004)
Br J Cancer
, vol.90
, pp. 1138-1143
-
-
Ugnat, A.M.1
Xie, L.2
Morriss, J.3
Semenciw, R.4
Mao, Y.5
-
7
-
-
0038505539
-
Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe
-
PMID:12845683; DOI:10.1002/ijc.11226
-
Sant M, Allemani C, Capocaccia R, Hakulinen T, Aareleid T, Coebergh JW, et al. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 2003; 106:416-22; PMID:12845683; DOI:10.1002/ijc.11226.
-
(2003)
Int J Cancer
, vol.106
, pp. 416-422
-
-
Sant, M.1
Allemani, C.2
Capocaccia, R.3
Hakulinen, T.4
Aareleid, T.5
Coebergh, J.W.6
-
8
-
-
36849069347
-
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer
-
PMID:17954709; DOI:10.1200/JCO.2007.14.2364
-
Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 2007; 25:5287-312; PMID:17954709; DOI:10.1200/JCO.2007.14.2364.
-
(2007)
J Clin Oncol
, vol.25
, pp. 5287-5312
-
-
Harris, L.1
Fritsche, H.2
Mennel, R.3
Norton, L.4
Ravdin, P.5
Taube, S.6
-
9
-
-
67651234166
-
Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women
-
PMID:19584157; DOI:10.1158/1078-0432.CCR-08-3307
-
Desmetz C, Bascoul-Mollevi C, Rochaix P, Lamy PJ, Kramar A, Rouanet P, et al. Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women. Clin Cancer Res 2009; 15:4733-41; PMID:19584157; DOI:10.1158/1078-0432.CCR-08-3307.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 4733-4741
-
-
Desmetz, C.1
Bascoul-Mollevi, C.2
Rochaix, P.3
Lamy, P.J.4
Kramar, A.5
Rouanet, P.6
-
10
-
-
0037227993
-
Harnessing immunity for cancer marker discovery
-
PMID:12511908; DOI:10.1038/nbt0103-37
-
Hanash S. Harnessing immunity for cancer marker discovery. Nat Biotechnol 2003; 21:37-8; PMID:12511908; DOI:10.1038/nbt0103-37.
-
(2003)
Nat Biotechnol
, vol.21
, pp. 37-38
-
-
Hanash, S.1
-
11
-
-
43049132944
-
Clinical proteomics and breast cancer: Strategies for diagnostic and therapeutic biomarker discovery
-
PMID:18407739; DOI:10.2217/14796694.4.2.271
-
Bertucci F, Goncalves A. Clinical proteomics and breast cancer: strategies for diagnostic and therapeutic biomarker discovery. Future Oncol 2008; 4:271-87; PMID:18407739; DOI:10.2217/14796694.4.2.271.
-
(2008)
Future Oncol
, vol.4
, pp. 271-287
-
-
Bertucci, F.1
Goncalves, A.2
-
12
-
-
30744433642
-
Advances, challenges and limitations in serum-proteome- based cancer diagnosis
-
PMID:16396491; DOI:10.1021/pr050271e
-
Ebert MP, Korc M, Malfertheiner P, Rocken C. Advances, challenges and limitations in serum-proteome- based cancer diagnosis. J Proteome Res 2006; 5:19-25; PMID:16396491; DOI:10.1021/pr050271e.
-
(2006)
J Proteome Res
, vol.5
, pp. 19-25
-
-
Ebert, M.P.1
Korc, M.2
Malfertheiner, P.3
Rocken, C.4
-
13
-
-
35648936560
-
Use of SELDITOF mass spectrometry for identification of new biomarkers: Potential and limitations
-
PMID:17970700; DOI:10.1515/CCLM.2007.351
-
Kiehntopf M, Siegmund R, Deufel T. Use of SELDITOF mass spectrometry for identification of new biomarkers: potential and limitations. Clin Chem Lab Med 2007; 45:1435-49; PMID:17970700; DOI:10.1515/CCLM.2007.351.
-
(2007)
Clin Chem Lab Med
, vol.45
, pp. 1435-1449
-
-
Kiehntopf, M.1
Siegmund, R.2
Deufel, T.3
-
14
-
-
0036324715
-
Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer
-
PMID:12142387
-
Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 2002; 48:1296-304; PMID:12142387.
-
(2002)
Clin Chem
, vol.48
, pp. 1296-1304
-
-
Li, J.1
Zhang, Z.2
Rosenzweig, J.3
Wang, Y.Y.4
Chan, D.W.5
-
15
-
-
33645215231
-
Serum biomarkers for detection of breast cancers: A prospective study
-
PMID:16322896; DOI:10.1007/s10549-005-9046-2
-
Mathelin C, Cromer A, Wendling C, Tomasetto C, Rio MC. Serum biomarkers for detection of breast cancers: a prospective study. Breast Cancer Res Treat 2006; 96:83-90; PMID:16322896; DOI:10.1007/s10549-005-9046-2.
-
(2006)
Breast Cancer Res Treat
, vol.96
, pp. 83-90
-
-
Mathelin, C.1
Cromer, A.2
Wendling, C.3
Tomasetto, C.4
Rio, M.C.5
-
16
-
-
20844448363
-
Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry
-
PMID:15692757; DOI:10.1007/s10549-004-1710-4
-
Pawlik TM, Fritsche H, Coombes K, Xiao L, Krishnamurthy S, Hunt K, et al. Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry. Breast Cancer Res Treat 2005; 89:149-57; PMID:15692757; DOI:10.1007/s10549-004-1710-4.
-
(2005)
Breast Cancer Res Treat
, vol.89
, pp. 149-157
-
-
Pawlik, T.M.1
Fritsche, H.2
Coombes, K.3
Xiao, L.4
Krishnamurthy, S.5
Hunt, K.6
-
17
-
-
0035666963
-
Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: Potential for new biomarkers to aid in the diagnosis of breast cancer
-
PMID:11790897
-
Paweletz CP, Trock B, Pennanen M, Tsangaris T, Magnant C, Liotta L, et al. Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer. Dis Markers 2001; 17:301-7; PMID:11790897.
-
(2001)
Dis Markers
, vol.17
, pp. 301-307
-
-
Paweletz, C.P.1
Trock, B.2
Pennanen, M.3
Tsangaris, T.4
Magnant, C.5
Liotta, L.6
-
18
-
-
28544442576
-
Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid
-
PMID:16322290; DOI:10.1158/1078-0432.CCR-05-1538
-
Li J. Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid. Clin Cancer Res 2005; 11:8312-20; PMID:16322290; DOI:10.1158/1078-0432.CCR-05-1538.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 8312-8320
-
-
Li, J.1
-
19
-
-
33750308455
-
MALDI-TOF serum protein profiling for the detection of breast cancer
-
PMID:17068384; DOI:10.1159/000095933
-
de Noo ME, Deelder A, van der Werff M, Ozalp A, Mertens B, Tollenaar R. MALDI-TOF serum protein profiling for the detection of breast cancer. Onkologie 2006; 29:501-6; PMID:17068384; DOI:10.1159/000095933.
-
(2006)
Onkologie
, vol.29
, pp. 501-506
-
-
De Noo, M.E.1
Deelder, A.2
Van Der Werff, M.3
Ozalp, A.4
Mertens, B.5
Tollenaar, R.6
-
20
-
-
33646259958
-
Clinical proteomics: Searching for better tumour markers with SELDI-TOF mass spectrometry
-
PMID:16600386; DOI:10.1016/j.tips.2006.03.003
-
Engwegen JYMN, Gast MCW, Schellens JHM, Beijnen JH. Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry. Trends Pharmacol Sci 2006; 27:251-9; PMID:16600386; DOI:10.1016/j.tips.2006.03.003.
-
(2006)
Trends Pharmacol Sci
, vol.27
, pp. 251-259
-
-
Engwegen, J.Y.M.N.1
Gast, M.C.W.2
Schellens, J.H.M.3
Beijnen, J.H.4
-
21
-
-
31044436630
-
Differential exoprotease activities confer tumor-specific serum peptidome patterns
-
PMID:16395409; DOI:10.1172/JCI26022
-
Villanueva J, Shaffer DR, Philip J, Chaparro CA, Erdjument-Bromage H, Olshen AB, et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest 2006; 116:271-84; PMID:16395409; DOI:10.1172/JCI26022.
-
(2006)
J Clin Invest
, vol.116
, pp. 271-284
-
-
Villanueva, J.1
Shaffer, D.R.2
Philip, J.3
Chaparro, C.A.4
Erdjument-Bromage, H.5
Olshen, A.B.6
-
22
-
-
65749105565
-
Surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry to detect breast cancer markers in tears and serum
-
PMID:19451091
-
Lebrecht A, Boehm D, Schmidt M, Koelbl H, Grus FH. Surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry to detect breast cancer markers in tears and serum. Cancer Genomics Proteomics 2009; 6:75-83; PMID:19451091.
-
(2009)
Cancer Genomics Proteomics
, vol.6
, pp. 75-83
-
-
Lebrecht, A.1
Boehm, D.2
Schmidt, M.3
Koelbl, H.4
Grus, F.H.5
-
23
-
-
34748919097
-
Design of recombinant antibody microarrays for complex proteome analysis: Choice of sample labelingtag and solid support
-
PMID:17787036; DOI:10.1002/pmic.200700025
-
Wingren C, Ingvarsson J, Dexlin L, Szul D, Borrebaeck CA. Design of recombinant antibody microarrays for complex proteome analysis: choice of sample labelingtag and solid support. Proteomics 2007; 7:3055-65; PMID:17787036; DOI:10.1002/pmic.200700025.
-
(2007)
Proteomics
, vol.7
, pp. 3055-3065
-
-
Wingren, C.1
Ingvarsson, J.2
Dexlin, L.3
Szul, D.4
Borrebaeck, C.A.5
-
24
-
-
34948911792
-
Design of recombinant antibody microarrays for serum protein profiling: Targeting of complement proteins
-
PMID:17696517; DOI:10.1021/pr070204f
-
Ingvarsson J, Larsson A, Sjoholm AG, Truedsson L, Jansson B, Borrebaeck CA, et al. Design of recombinant antibody microarrays for serum protein profiling: targeting of complement proteins. J Proteome Res 2007; 6:3527-36; PMID:17696517; DOI:10.1021/pr070204f.
-
(2007)
J Proteome Res
, vol.6
, pp. 3527-3536
-
-
Ingvarsson, J.1
Larsson, A.2
Sjoholm, A.G.3
Truedsson, L.4
Jansson, B.5
Borrebaeck, C.A.6
-
25
-
-
78651302578
-
Proteome analysis of human pancreatic cancer cell lines with highly liver metastatic potential by antibody microarray
-
PMID:20960035; DOI:10.1007/s11010-010-0619-y
-
Shi W, Meng Z, Chen Z, Luo J, Liu L. Proteome analysis of human pancreatic cancer cell lines with highly liver metastatic potential by antibody microarray. Mol Cell Biochem 2011; 347:117-25; PMID:20960035; DOI:10.1007/s11010-010-0619-y.
-
(2011)
Mol Cell Biochem
, vol.347
, pp. 117-125
-
-
Shi, W.1
Meng, Z.2
Chen, Z.3
Luo, J.4
Liu, L.5
-
26
-
-
79953647946
-
Repeatedly identified differentially expressed proteins (RIDEPs) from antibody microarray proteomic analysis
-
PMID:21338725; DOI:10.1016/j.jprot.2011.02.014
-
Hodgkinson VC, Elfadl D, Drew PJ, Lind MJ, Cawkwell L. Repeatedly identified differentially expressed proteins (RIDEPs) from antibody microarray proteomic analysis. J Proteomics 2011; 74:698-703; PMID:21338725; DOI:10.1016/j.jprot.2011.02.014.
-
(2011)
J Proteomics
, vol.74
, pp. 698-703
-
-
Hodgkinson, V.C.1
Elfadl, D.2
Drew, P.J.3
Lind, M.J.4
Cawkwell, L.5
-
27
-
-
36849039867
-
Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays
-
PMID:17954908; DOI:10.1073/pnas.0708572104
-
Hudson ME, Pozdnyakova I, Haines K, Mor G, Snyder M. Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc Natl Acad Sci USA 2007; 104:17494-9; PMID:17954908; DOI:10.1073/pnas.0708572104.
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 17494-17499
-
-
Hudson, M.E.1
Pozdnyakova, I.2
Haines, K.3
Mor, G.4
Snyder, M.5
-
28
-
-
79951878064
-
Protein microarrays for systems biology
-
(Shanghai) PMID:21257623; DOI:10.1093/abbs/gmq127
-
Yang L, Guo S, Li Y, Zhou S, Tao S. Protein microarrays for systems biology. Acta Biochim Biophys Sin (Shanghai) 2011; 43:161-71; PMID:21257623; DOI:10.1093/abbs/gmq127.
-
(2011)
Acta Biochim Biophys Sin
, vol.43
, pp. 161-171
-
-
Yang, L.1
Guo, S.2
Li, Y.3
Zhou, S.4
Tao, S.5
-
29
-
-
38749122786
-
Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays
-
PMID:18171612; DOI:10.1016/j.ejca.2007.11.025
-
Carlsson A, Wingren C, Ingvarsson J, Ellmark P, Baldertorp B, Fernö M, et al. Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays. Eur J Cancer 2008; 44:472-80; PMID:18171612; DOI:10.1016/j.ejca.2007.11.025.
-
(2008)
Eur J Cancer
, vol.44
, pp. 472-480
-
-
Carlsson, A.1
Wingren, C.2
Ingvarsson, J.3
Ellmark, P.4
Baldertorp, B.5
Fernö, M.6
-
30
-
-
33750030016
-
Cytokines in breast cancer
-
PMID:16931107; DOI:10.1016/j.cytogfr.2006.07.002
-
Nicolini A, Carpi A, Rossi G. Cytokines in breast cancer. Cytokine Growth Factor Rev 2006; 17:325- 37; PMID:16931107; DOI:10.1016/j.cytogfr.2006.07.002.
-
(2006)
Cytokine Growth Factor Rev
, vol.17
, pp. 325-337
-
-
Nicolini, A.1
Carpi, A.2
Rossi, G.3
-
31
-
-
33845449066
-
Downregulated expression of complement factor I: A potential suppressive protein for gastric cancer identified by serum proteome analysis
-
PMID:17067565; DOI:10.1016/j.cca.2006.09.005
-
Liu W, Liu B, Xin L, Zhang Y, Chen X, Zhu Z, et al. Downregulated expression of complement factor I: a potential suppressive protein for gastric cancer identified by serum proteome analysis. Clin Chim Acta 2007; 377:119-26; PMID:17067565; DOI:10.1016/j.cca.2006.09.005.
-
(2007)
Clin Chim Acta
, vol.377
, pp. 119-126
-
-
Liu, W.1
Liu, B.2
Xin, L.3
Zhang, Y.4
Chen, X.5
Zhu, Z.6
-
32
-
-
0038365368
-
Analysis of microarray data using Z-score transformation
-
PMID:12707371; DOI:10.1016/S1525-1578(10)60455-2
-
Cheadle C, Vawter MP, Freed WJ, Becker KG. Analysis of microarray data using Z-score transformation. J Mol Diagn 2003; 5:73-81; PMID:12707371; DOI:10.1016/S1525-1578(10)60455-2.
-
(2003)
J Mol Diagn
, vol.5
, pp. 73-81
-
-
Cheadle, C.1
Vawter, M.P.2
Freed, W.J.3
Becker, K.G.4
-
33
-
-
0035918882
-
Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1
-
PMID:11416112; DOI:10.1093/jnci/93.12.913
-
Jänicke F, Prechtl A, Thomssen C, Harbeck N, Meisner C, Untch M, et al. Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1. J Natl Cancer Inst 2001; 93:913-20; PMID:11416112; DOI:10.1093/jnci/93.12.913.
-
(2001)
J Natl Cancer Inst
, vol.93
, pp. 913-920
-
-
Jänicke, F.1
Prechtl, A.2
Thomssen, C.3
Harbeck, N.4
Meisner, C.5
Untch, M.6
-
34
-
-
34247282875
-
Contribution of oncoproteomics to cancer biomarker discovery
-
PMID:17407558; DOI:10.1186/1476-4598-6-25
-
Cho WC. Contribution of oncoproteomics to cancer biomarker discovery. Mol Cancer 2007; 6:25; PMID:17407558; DOI:10.1186/1476-4598-6-25.
-
(2007)
Mol Cancer
, vol.6
, pp. 25
-
-
Cho, W.C.1
-
35
-
-
34147209189
-
Preanalytic influence of sample handling on SELDI-TOF serum protein profiles
-
PMID:17303688; DOI:10.1373/clinchem.2006.080101
-
Timms JF, Arslan-Low E, Gentry-Maharaj A, Luo Z, T'Jampens D, Podust VN, et al. Preanalytic influence of sample handling on SELDI-TOF serum protein profiles. Clin Chem 2007; 53:645-56; PMID:17303688; DOI:10.1373/clinchem.2006. 080101.
-
(2007)
Clin Chem
, vol.53
, pp. 645-656
-
-
Timms, J.F.1
Arslan-Low, E.2
Gentry-Maharaj, A.3
Luo, Z.4
T'Jampens, D.5
Podust, V.N.6
-
36
-
-
26844545417
-
Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis
-
PMID:16117833; DOI:10.1186/1471-2407-5-110
-
Gao WM, Kuick R, Orchekowski RP, Misek DE, Qiu J, Greenberg AK, et al. Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis. BMC Cancer 2005; 5:110; PMID:16117833; DOI:10.1186/1471-2407-5-110.
-
(2005)
BMC Cancer
, vol.5
, pp. 110
-
-
Gao, W.M.1
Kuick, R.2
Orchekowski, R.P.3
Misek, D.E.4
Qiu, J.5
Greenberg, A.K.6
-
37
-
-
0035887145
-
Profiling of cancer cells using protein microarrays: Discovery of novel radiation-regulated proteins
-
PMID:11606398
-
Sreekumar A, Nyati MK, Varambally S, Barrette TR, Ghosh D, Lawrence TS, et al. Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins. Cancer Res 2001; 61:7585-93; PMID:11606398.
-
(2001)
Cancer Res
, vol.61
, pp. 7585-7593
-
-
Sreekumar, A.1
Nyati, M.K.2
Varambally, S.3
Barrette, T.R.4
Ghosh, D.5
Lawrence, T.S.6
-
38
-
-
77953147573
-
Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies
-
PMID:20164060; DOI:10.1074/mcp.M900419-MCP200
-
Schröder C, Jacob A, Tonack S, Radon TP, Sill M, Zucknick M, et al. Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies. Mol Cell Proteomics 2010; 9:1271-80; PMID:20164060; DOI:10.1074/mcp.M900419-MCP200.
-
(2010)
Mol Cell Proteomics
, vol.9
, pp. 1271-1280
-
-
Schröder, C.1
Jacob, A.2
Tonack, S.3
Radon, T.P.4
Sill, M.5
Zucknick, M.6
-
39
-
-
19644388098
-
Serum protein markers for early detection of ovarian cancer
-
PMID:15890779; DOI:10.1073/pnas.0502178102
-
Mor G, Visintin I, Lai Y, Zhao H, Schwartz P, Rutherford T, et al. Serum protein markers for early detection of ovarian cancer. Proc Natl Acad Sci USA 2005; 102:7677-82; PMID:15890779; DOI:10.1073/pnas.0502178102.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 7677-7682
-
-
Mor, G.1
Visintin, I.2
Lai, Y.3
Zhao, H.4
Schwartz, P.5
Rutherford, T.6
-
40
-
-
33746820320
-
Antibody microarray-based oncoproteomics
-
PMID:16856804; DOI:10.1517/14712598.6.8.833
-
Borrebaeck CA. Antibody microarray-based oncoproteomics. Expert Opin Biol Ther 2006; 6:833-8; PMID:16856804; DOI:10.1517/14712598.6.8.833.
-
(2006)
Expert Opin Biol Ther
, vol.6
, pp. 833-838
-
-
Borrebaeck, C.A.1
-
41
-
-
14544270987
-
Screening for breast cancer
-
PMID:15755947; DOI:10.1001/jama.293.10.1245
-
Elmore JG, Armstrong K, Lehman CD, Fletcher SW. Screening for breast cancer. JAMA 2005; 293:1245-56; PMID:15755947; DOI:10.1001/jama.293.10.1245.
-
(2005)
JAMA
, vol.293
, pp. 1245-1256
-
-
Elmore, J.G.1
Armstrong, K.2
Lehman, C.D.3
Fletcher, S.W.4
-
43
-
-
55249086768
-
Proteomics-based identification of HSP60 as a tumor-associated antigen in early stage breast cancer and ductal carcinoma in situ
-
PMID:18683965; DOI:10.1021/pr800130d
-
Desmetz C, Bibeau F, Boissiere F, Bellet V, Rouanet P, Maudelonde T, et al. Proteomics-based identification of HSP60 as a tumor-associated antigen in early stage breast cancer and ductal carcinoma in situ. J Proteome Res 2008; 7:3830-7; PMID:18683965; DOI:10.1021/pr800130d.
-
(2008)
J Proteome Res
, vol.7
, pp. 3830-3837
-
-
Desmetz, C.1
Bibeau, F.2
Boissiere, F.3
Bellet, V.4
Rouanet, P.5
Maudelonde, T.6
-
44
-
-
33751170698
-
Mitochondrial chaperones in cancer: From molecular biology to clinical diagnostics
-
PMID:16861898; DOI:10.4161/cbt.5.7.2975
-
Czarnecka AM, Campanella C, Zummo G, Cappello F. Mitochondrial chaperones in cancer: from molecular biology to clinical diagnostics. Cancer Biol Ther 2006; 5:714-20; PMID:16861898; DOI:10.4161/cbt.5.7.2975.
-
(2006)
Cancer Biol Ther
, vol.5
, pp. 714-720
-
-
Czarnecka, A.M.1
Campanella, C.2
Zummo, G.3
Cappello, F.4
-
45
-
-
0029145456
-
Immunohistochemical detection of estrogen receptor in invasive human breast cancer: Correlation with heat shock proteins, pS2 and oncogene products
-
PMID:7637953; DOI:10.1159/000227491
-
Takahashi S, Narimatsu E, Asanuma H, Okazaki M, Okazaki A, Hirata K, et al. Immunohistochemical detection of estrogen receptor in invasive human breast cancer: correlation with heat shock proteins, pS2 and oncogene products. Oncology 1995; 52:371-5; PMID:7637953; DOI:10.1159/000227491.
-
(1995)
Oncology
, vol.52
, pp. 371-375
-
-
Takahashi, S.1
Narimatsu, E.2
Asanuma, H.3
Okazaki, M.4
Okazaki, A.5
Hirata, K.6
-
46
-
-
34547183458
-
MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2
-
PMID:17505812; DOI:10.1007/s10585-007-9071-0
-
Mendes O, Kim HT, Lungu G, Stoica G. MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2. Clin Exp Metastasis 2007; 24:341-51; PMID:17505812; DOI:10.1007/s10585-007-9071-0.
-
(2007)
Clin Exp Metastasis
, vol.24
, pp. 341-351
-
-
Mendes, O.1
Kim, H.T.2
Lungu, G.3
Stoica, G.4
-
47
-
-
33750480232
-
Differential reactions of microglia to brain metastasis of lung cancer
-
PMID:17088948; DOI:10.2119/2006-00033.He
-
He BP, Wang JJ, Zhang X, Wu Y, Wang M, Bay BH, et al. Differential reactions of microglia to brain metastasis of lung cancer. Mol Med 2006; 12:161-70; PMID:17088948; DOI:10.2119/2006-00033.He.
-
(2006)
Mol Med
, vol.12
, pp. 161-170
-
-
He, B.P.1
Wang, J.J.2
Zhang, X.3
Wu, Y.4
Wang, M.5
Bay, B.H.6
-
48
-
-
0018649570
-
Fluctuation of serum complement levels in children with neuroblastoma
-
PMID:455227; DOI:10.1002/1097-0142(197906)43:6<2399:: AIDCNCR2820430634>3.0.CO;2-T
-
Carli M, Bucolo C, Pannunzio MT, Ongaro G, Businaro R, Revoltella R. Fluctuation of serum complement levels in children with neuroblastoma. Cancer 1979; 43:2399-404; PMID:455227; DOI:10.1002/1097-0142(197906)43:6<2399:: AIDCNCR2820430634>3.0.CO;2-T.
-
(1979)
Cancer
, vol.43
, pp. 2399-2404
-
-
Carli, M.1
Bucolo, C.2
Pannunzio, M.T.3
Ongaro, G.4
Businaro, R.5
Revoltella, R.6
-
49
-
-
0026437987
-
Immunoglobulins and complement components levels in patients with lung cancer
-
PMID:1323139
-
Gminski J, Mykala-Ciesla J, Machalski M, Drozdz M, Najda J. Immunoglobulins and complement components levels in patients with lung cancer. Rom J Intern Med 1992; 30:39-44; PMID:1323139.
-
(1992)
Rom J Intern Med
, vol.30
, pp. 39-44
-
-
Gminski, J.1
Mykala-Ciesla, J.2
Machalski, M.3
Drozdz, M.4
Najda, J.5
-
50
-
-
0017661843
-
Serum complement levels in patients with digestive tract carcinomas and other neoplastic diseases
-
PMID:896122; DOI:10.1159/000225191
-
Maness PF, Orengo A. Serum complement levels in patients with digestive tract carcinomas and other neoplastic diseases. Oncology 1977; 34:87-9; PMID:896122; DOI:10.1159/000225191.
-
(1977)
Oncology
, vol.34
, pp. 87-89
-
-
Maness, P.F.1
Orengo, A.2
-
51
-
-
67650599134
-
Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation timeof- flight mass spectrometry (SELDI-TOF MS)
-
PMID:19416081; DOI:10.1515/CCLM.2009.151
-
Gast MCW, van Gils CH, Wessels LFA, Harris N, Bonfrer JMG, Rutgers EJT, et al. Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation timeof- flight mass spectrometry (SELDI-TOF MS). Clin Chem Lab Med 2009; 47:694-705; PMID:19416081; DOI:10.1515/CCLM.2009.151.
-
(2009)
Clin Chem Lab Med
, vol.47
, pp. 694-705
-
-
Gast, M.C.W.1
Van Gils, C.H.2
Wessels, L.F.A.3
Harris, N.4
Bonfrer, J.M.G.5
Rutgers, E.J.T.6
-
52
-
-
7344256177
-
Serological detection of heat shock protein hsp27 in normal and breast cancer patients
-
PMID:9752987
-
Fanelli MA, Cuello Carrion FD, Dekker J, Schoemaker J, Ciocca DR. Serological detection of heat shock protein hsp27 in normal and breast cancer patients. Cancer Epidemiol Biomarkers Prev 1998; 7:791-5; PMID:9752987.
-
(1998)
Cancer Epidemiol Biomarkers Prev
, vol.7
, pp. 791-795
-
-
Fanelli, M.A.1
Cuello Carrion, F.D.2
Dekker, J.3
Schoemaker, J.4
Ciocca, D.R.5
-
53
-
-
0037311919
-
TM4: A free, open-source system for microarray data management and analysis
-
PMID:12613259
-
Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003; 34:374-8; PMID:12613259.
-
(2003)
Biotechniques
, vol.34
, pp. 374-378
-
-
Saeed, A.I.1
Sharov, V.2
White, J.3
Li, J.4
Liang, W.5
Bhagabati, N.6
|